22-42130692-G-A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP3BP4_StrongBP6_Very_StrongBA1

The NM_000106.6(CYP2D6):​c.100C>T​(p.Pro34Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.212 in 1,605,342 control chromosomes in the GnomAD database, including 48,398 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign,drug response,other (★★).

Frequency

Genomes: 𝑓 0.19 ( 4032 hom., cov: 31)
Exomes 𝑓: 0.21 ( 44366 hom. )

Consequence

CYP2D6
NM_000106.6 missense

Scores

7
4
6

Clinical Significance

Likely benign; drug response; other criteria provided, multiple submitters, no conflicts B:1O:5

Conservation

PhyloP100: 7.37

Publications

646 publications found
Variant links:
Genes affected
CYP2D6 (HGNC:2625): (cytochrome P450 family 2 subfamily D member 6) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
NDUFA6-DT (HGNC:45273): (NDUFA6 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 8: AlphaMissense, BayesDel_noAF, Cadd, Eigen, MutationAssessor, PROVEAN, REVEL, REVEL [when BayesDel_addAF, max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster, PrimateAI was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.002202928).
BP6
Variant 22-42130692-G-A is Benign according to our data. Variant chr22-42130692-G-A is described in ClinVar as Likely_benign|drug_response|other. ClinVar VariationId is 16893.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.525 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000106.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP2D6
NM_000106.6
MANE Select
c.100C>Tp.Pro34Ser
missense
Exon 1 of 9NP_000097.3
CYP2D6
NM_001025161.3
c.100C>Tp.Pro34Ser
missense
Exon 1 of 8NP_001020332.2P10635-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP2D6
ENST00000645361.2
MANE Select
c.100C>Tp.Pro34Ser
missense
Exon 1 of 9ENSP00000496150.1P10635-1
CYP2D6
ENST00000359033.4
TSL:1
c.100C>Tp.Pro34Ser
missense
Exon 1 of 8ENSP00000351927.4P10635-2
CYP2D6
ENST00000360124.10
TSL:1
n.100C>T
non_coding_transcript_exon
Exon 1 of 8ENSP00000353241.6H7BY38

Frequencies

GnomAD3 genomes
AF:
0.191
AC:
28692
AN:
150496
Hom.:
4035
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.125
Gnomad AMI
AF:
0.301
Gnomad AMR
AF:
0.153
Gnomad ASJ
AF:
0.246
Gnomad EAS
AF:
0.541
Gnomad SAS
AF:
0.168
Gnomad FIN
AF:
0.113
Gnomad MID
AF:
0.114
Gnomad NFE
AF:
0.223
Gnomad OTH
AF:
0.177
GnomAD2 exomes
AF:
0.209
AC:
50363
AN:
241260
AF XY:
0.207
show subpopulations
Gnomad AFR exome
AF:
0.123
Gnomad AMR exome
AF:
0.123
Gnomad ASJ exome
AF:
0.242
Gnomad EAS exome
AF:
0.577
Gnomad FIN exome
AF:
0.114
Gnomad NFE exome
AF:
0.217
Gnomad OTH exome
AF:
0.199
GnomAD4 exome
AF:
0.214
AC:
311907
AN:
1454734
Hom.:
44366
Cov.:
35
AF XY:
0.213
AC XY:
153913
AN XY:
723174
show subpopulations
African (AFR)
AF:
0.121
AC:
4013
AN:
33268
American (AMR)
AF:
0.126
AC:
5551
AN:
44140
Ashkenazi Jewish (ASJ)
AF:
0.245
AC:
6380
AN:
26062
East Asian (EAS)
AF:
0.481
AC:
18972
AN:
39452
South Asian (SAS)
AF:
0.157
AC:
13392
AN:
85306
European-Finnish (FIN)
AF:
0.119
AC:
6303
AN:
52978
Middle Eastern (MID)
AF:
0.139
AC:
795
AN:
5708
European-Non Finnish (NFE)
AF:
0.220
AC:
243823
AN:
1107808
Other (OTH)
AF:
0.211
AC:
12678
AN:
60012
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.536
Heterozygous variant carriers
0
10079
20158
30237
40316
50395
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8196
16392
24588
32784
40980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.190
AC:
28678
AN:
150608
Hom.:
4032
Cov.:
31
AF XY:
0.186
AC XY:
13671
AN XY:
73610
show subpopulations
African (AFR)
AF:
0.124
AC:
5060
AN:
40702
American (AMR)
AF:
0.153
AC:
2318
AN:
15162
Ashkenazi Jewish (ASJ)
AF:
0.246
AC:
851
AN:
3462
East Asian (EAS)
AF:
0.541
AC:
2757
AN:
5092
South Asian (SAS)
AF:
0.167
AC:
793
AN:
4760
European-Finnish (FIN)
AF:
0.113
AC:
1192
AN:
10590
Middle Eastern (MID)
AF:
0.119
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
0.223
AC:
15038
AN:
67566
Other (OTH)
AF:
0.175
AC:
364
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.559
Heterozygous variant carriers
0
781
1562
2344
3125
3906
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
304
608
912
1216
1520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.212
Hom.:
1373
Bravo
AF:
0.192
ESP6500AA
AF:
0.120
AC:
525
ESP6500EA
AF:
0.224
AC:
1924
ExAC
AF:
0.204
AC:
24731
Asia WGS
AF:
0.287
AC:
996
AN:
3464

ClinVar

ClinVar submissions
Significance:Likely benign; drug response; other
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not specified (1)
-
-
-
Debrisoquine, poor metabolism of (1)
-
-
-
Deutetrabenazine response (1)
-
-
-
not provided (1)
-
-
-
Tamoxifen response (1)
-
-
-
Tramadol response (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.76
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Pathogenic
0.15
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.075
T
Eigen
Pathogenic
0.72
Eigen_PC
Uncertain
0.55
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.82
T
MetaRNN
Benign
0.0022
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Pathogenic
4.1
H
PhyloP100
7.4
PrimateAI
Benign
0.41
T
PROVEAN
Pathogenic
-7.4
D
REVEL
Pathogenic
0.73
Sift
Uncertain
0.023
D
Sift4G
Uncertain
0.025
D
Vest4
0.21
MPC
0.48
ClinPred
0.078
T
GERP RS
3.5
PromoterAI
0.0068
Neutral
Varity_R
0.55
gMVP
0.84
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1065852; hg19: chr22-42526694; COSMIC: COSV62243216; COSMIC: COSV62243216; API